The IGBMC spinout was set up by Satt Conectus and is now seeking a listing in the US with a price range of $15 to $17.

Th heart disease treatment developer has secured $248m in funding since being formed to exploit UT Southwestern and Gladstone Institute research.

University of Washington spinout Icosavax has filed for an initial public offering on the Nasdaq Global Select Market, with financial terms yet to be set.

UC Berkeley’s cell therapy developer has filed for an initial public offering.

Less than a year after raising $72.6m in its series A round, Aerovate Therapeutics has gone public following an IPO worth more than $121m.

CMU-founded language learning platform developer Duolingo was valued at $2.4bn as of its last funding round in November 2020.

The Stanford spinout has gone public following a $238m IPO, after revealing that the university was also among the series B investors.

Karolinska Development-backed Biosergen has begun trading on the Nasdaq First Growth Market, having already undertaken a $5.9m offering earlier this month.

University of Oxford and OSI are set to exit the medical diagnostics software provider in a flotation with a $75m placeholder target.

The cancer therapy developer and Jackson Laboratory spinout floated at the upper end of its range and now has a $600m market cap.